References
- American Psychiatric Association. Diagnostic and Statistical Man-ual of Mental Disorders. 4th ed. Washington, DC: American Psy-chiatric Association; 2000
- Wender PH, Wolf LE, Wasserstein J: Adults with ADHD: An overview. Ann N Y Acad Sci. 2001; 931:1–16
- Murphy K, Barldey RA: Attention deficit hyperactivity disorder adults: Comorbidities and adaptive impairments. Comprehensive Psychiatry 1996; 37:393–401
- Biederman J, Faraone S, Spencer T, Wilens T, Norman D, Lapey K, Mick E, Lehman, B.K. Doyle A: Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 1792–1798
- Michelson D, Adler L, Spencer T, Reimherr F, West S, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D: Atomoxetine in adults with ADHD: Two randomized placebo-controlled studies. Biol Psychiatry 2003; 53:112–120
- Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR, Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Harder D: Once-daily atomoxetine treat-ment for children and adolescents with attention deficit hyperac-tivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 2002; 159:1896–1901
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000
- Conners C, Erhardt D, Sparrow E: Conners' adult ADHD rating scales technical manual. North Tonawanda, NY: Multi-Health Systems Inc. 1999
- Arizona Board of Regents. ASEX Scales: General Instructions for Clinicians Administering the Scale. Tucson, AZ: University of Arizona, 1997
- Strattera® [Package Insert]. Indianapolis, IN: Eli Lilly and Com-pany; 2003
- Adler LA, Spencer TJ, Milton DR, Moore RJ, Michelson D: Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: An interim analysis. J Clin Psychiatry 2005; 66: 294–299